Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in F...(f a module for the Company's Symphony so...),Health
f a module for the Company's Symphony software suite that
allows blood bank customers to automate applications in their
manufacturing and distribution operations
-- Acquisition of the TEG(R) Thrombelastograph(R) Hemostasis Analyzer
business which is expected to add more than $16 million in annual
revenues
-- Acquisition of Infonale which gives Haemonetics strategic expertise in
hospital blood management consulting services
-- Restructuring of European and Asian operations which reported revenue
growth of 11% and 19%, respectively
-- Completion of Phase I of an enterprise resource planning initiative
which converted all geographies, sales, service and financial functions
to a new system
ANNUAL PRODUCT LINE GROWTH
Among the product lines, plasma disposables revenue was $40 million for the quarter, up 32%. Annual plasma disposables revenue was $155 million, up 22%. Plasma disposable sales benefited from continued growth in U.S. and European plasma collections as well as from Haemonetics' collection growth at new customer sites. Haemonetics expects that growth in the plasma market will continue to drive strong plasma sales for the next several years.
Blood bank disposables revenue was $36 million for the quarter, up 11%. Annual blood bank disposables revenue was $136 million, up 8%. Blood bank growth was driven by strong sales in Europe and Asia as the Company sees early benefits from last year's reorganization initiatives.
Red cell disposables revenue was $12 million for the quarter, up 7%. Annual red cell disposables revenue was $46 million, up 7%. Strong equipment sales of the newest generation Cymbal(R) automated blood collection system and the MCS(R)+ mobile collection system in the first half of the year drove strong product line sales. Including equipment, total revenues for the red cell product line grew 13% in the year.
Software and
'/>"/>
| SOURCE Haemonetics Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. Haemonetics Appoints Executive Leadership of European Operations
4. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
5. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
6. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
7. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |